Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 6.4
-4.19 %
$ 236 M
Market Cap
49.23
P/E
INCOME STATEMENT
128 M
REVENUE
9.33 M
OPERATING INCOME
9.33 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Lifecore Biomedical, Inc.
| Revenue | 128 M |
| Cost Of Revenue | 86.4 M |
| Gross Profit | 41.8 M |
| Operating Expenses | 49 M |
| Operating Income | 9.33 M |
| Other Expenses | 0 |
| Net Income | 9.33 M |
Income Statement
Millions
| May-2024 | May-2023 | May-2022 | May-2021 | May-2020 | May-2019 | May-2018 | May-2017 | May-2016 | May-2015 | May-2014 | May-2013 | May-2012 | May-2011 | May-2010 | May-2009 | May-2008 | May-2007 | May-2006 | May-2005 | May-2004 | May-2003 | Oct-2002 | Oct-2001 | Oct-2000 | Oct-1999 | Oct-1998 | Oct-1997 | Oct-1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||||||
| Revenue | 128.3 | 103.3 | 185.8 | 544.2 | 590.4 | 557.6 | 524.2 | 532.3 | 541.1 | 539.3 | 476.8 | 441.7 | 317.6 | 276.7 | 238.2 | 235.9 | 238.5 | 210.5 | 232.0 | 205.2 | 192.1 | 0 | 183.2 | 190.9 | 209.6 | 35.4 | 33.5 | 9.5 | 2.5 |
| GROSS PROFIT | |||||||||||||||||||||||||||||
| Cost Of Revenue | 86.4 | 76.0 | 135.2 | 462.7 | 515.4 | 476.6 | 445.9 | 449.1 | 470.1 | 473.9 | 414.2 | 378.9 | 265.4 | 230.0 | 204.5 | 201.7 | 200.3 | 178.1 | 191.9 | 173.3 | 162.3 | 0 | 151.8 | 163.3 | 170.1 | 19.3 | 18.2 | 5.1 | 0.5 |
| Gross Profit | 41.9 | 27.3 | 50.6 | 81.5 | 75.0 | 81.0 | 78.3 | 83.2 | 71.0 | 65.4 | 62.6 | 62.8 | 52.1 | 46.7 | 33.8 | 34.3 | 38.2 | 32.4 | 40.0 | 32.0 | 29.8 | 0 | 31.3 | 27.6 | 39.4 | 16.1 | 15.3 | 4.4 | 2.0 |
| OPERATING INCOME | |||||||||||||||||||||||||||||
| Operating Expenses | 49.0 | 51.3 | 50.5 | 75.6 | 83.3 | 75.5 | 64.8 | 67.7 | 56.7 | 46.9 | 42.4 | 37.9 | 36.1 | 33.9 | 22.1 | 21.7 | 23.1 | 2.0 | 31.0 | 26.0 | 25.7 | 0 | 30.1 | 30.2 | 39.6 | 19.2 | 18.6 | 13.4 | 7.6 |
| Selling, General and Administrative Expenses | 40.5 | 43.0 | 42.6 | 65.4 | 72.2 | 64.1 | 52.0 | 58.2 | 49.5 | 40.0 | 35.2 | 32.5 | 26.5 | 24.6 | 17.7 | 18.0 | 19.8 | 21.6 | 28.0 | 23.4 | 22.0 | 0 | 26.4 | 27.0 | 28.9 | 11.2 | 10.8 | 4.7 | 3.3 |
| Research and Development Expenses | 8.6 | 8.2 | 7.8 | 10.2 | 11.1 | 11.5 | 12.8 | 9.5 | 7.2 | 7.0 | 7.2 | 9.3 | 9.6 | 9.3 | 4.4 | 3.7 | 3.3 | 3.1 | 3.0 | 2.5 | 3.7 | 0 | 3.7 | 3.3 | 4.7 | 5.8 | 5.7 | 7.6 | 3.8 |
| Operating Income | 9.3 | (26.1) | 3.5 | (6.9) | (8.3) | (8.0) | 11.8 | 15.5 | (19.8) | 18.5 | 20.2 | 24.9 | 14.6 | 8.0 | 11.7 | 12.6 | 15.2 | 30.4 | 9.0 | 6.0 | 4.1 | 0 | 1.3 | (2.6) | (0.2) | (3.1) | (3.3) | (9.0) | (5.6) |
| PRE-TAX INCOME | |||||||||||||||||||||||||||||
| Interest Income Expense | 18.1 | 18.2 | 17.3 | 15.3 | 9.6 | 5.2 | 1.9 | 1.8 | 2.0 | 1.8 | 1.6 | 2.0 | 0.9 | 0.8 | 88 K | 8 K | (1.7) | (23.9) | 24 K | 4 K | 29 K | 0 | 0 | 2.2 | 4.3 | (0.4) | (1.3) | (1.7) | 0 |
| Total Other Income | 0.2 | (42.1) | (8.9) | (21.0) | (4.8) | (1.8) | 2.8 | (0.5) | 0.9 | 3.0 | 9.7 | 7.4 | 5.7 | 0.4 | 0.7 | 0.7 | 2.2 | 1.7 | 24 K | 4 K | 29 K | 0 | (1.1) | (2.2) | (1.3) | 0.3 | 0.6 | 1.7 | 0.2 |
| Pre-Tax Income | 9.5 | (68.7) | (51.9) | (40.5) | (51.3) | 3.6 | 16.4 | 15.0 | (18.9) | 21.5 | 29.9 | 32.3 | 20.3 | 8.4 | 8.7 | 13.3 | 16.9 | 31.6 | 9.0 | 6.0 | 4.1 | 0 | 0.2 | (4.8) | (2.1) | (2.7) | (2.7) | (7.3) | (4.1) |
| NET INCOME | |||||||||||||||||||||||||||||
| Tax Provision | 0.2 | 0.3 | (5.8) | (7.8) | (13.1) | 1.5 | (9.4) | 4.3 | (7.4) | 7.7 | 10.6 | 9.5 | 7.2 | 4.2 | 4.3 | 5.6 | 3.4 | 2.5 | 0.4 | 0.6 | 1.1 | 0 | 2.7 | 16.2 | 42 K | 100 K | 0.2 | (2.1) | (1.4) |
| Net Income | 12.0 | (102.2) | (46.1) | (32.7) | (38.2) | 2.1 | 24.8 | 10.6 | (11.6) | 13.5 | 19.1 | 22.6 | 12.7 | 3.9 | 4.0 | 7.7 | 13.5 | 29.2 | 8.7 | 5.4 | 2.9 | 0 | (1.5) | (18.8) | (4.0) | (2.8) | (2.9) | (8.6) | (4.2) |
| EPS | 0.39 | 3.41 | 1.56 | 1.12 | 1.31 | 0.0748 | 0.9 | 0.39 | 0.43 | 0.5 | 0.71 | 0.87 | 0.5 | 0.15 | 0.15 | 0.29 | 0.52 | 1.16 | 0.35 | 0.23 | 0.11 | 0 | 0.0818 | 1.15 | 0.25 | 0.28 | 0.23 | 0.77 | 0.54 |